Cargando…
Primary Hyperaldosteronism in End-Stage Renal Disease: Diagnostic Challenges and Treatment Considerations
An adrenal incidentaloma is defined as an adrenal mass measuring at least 1 cm that is discovered surreptitiously in an imaging study done for reasons other than the evaluation of adrenal disease. The increase in the prevalence of adrenal incidentalomas has paralleled the increase in diagnostic imag...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478770/ https://www.ncbi.nlm.nih.gov/pubmed/32923203 http://dx.doi.org/10.7759/cureus.9599 |
_version_ | 1783580128139280384 |
---|---|
author | Chand, Raj Tandukar, Srijan Asmil, Sadiyah Chico, Michelle |
author_facet | Chand, Raj Tandukar, Srijan Asmil, Sadiyah Chico, Michelle |
author_sort | Chand, Raj |
collection | PubMed |
description | An adrenal incidentaloma is defined as an adrenal mass measuring at least 1 cm that is discovered surreptitiously in an imaging study done for reasons other than the evaluation of adrenal disease. The increase in the prevalence of adrenal incidentalomas has paralleled the increase in diagnostic imaging done for evaluation of other abdominal pathologies. However, most of these adrenal incidentalomas are benign non-hyperfunctioning adenomas. When an adrenal incidentaloma is discovered, the simultaneous presence of hypokalemia, metabolic alkalosis, mild hypernatremia, and mild to severe drug-resistant hypertension may alert a clinician to underlying primary hyperaldosteronism. We present a case of adrenal incidentaloma noted in a patient with end-stage renal disease on hemodialysis which presented a diagnostic challenge due to the correction of metabolic parameters with hemodialysis. The patient was found to have an aldosterone-producing adenoma based on an elevated aldosterone-to-renin ratio and was started on a mineralocorticoid antagonist. |
format | Online Article Text |
id | pubmed-7478770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-74787702020-09-11 Primary Hyperaldosteronism in End-Stage Renal Disease: Diagnostic Challenges and Treatment Considerations Chand, Raj Tandukar, Srijan Asmil, Sadiyah Chico, Michelle Cureus Endocrinology/Diabetes/Metabolism An adrenal incidentaloma is defined as an adrenal mass measuring at least 1 cm that is discovered surreptitiously in an imaging study done for reasons other than the evaluation of adrenal disease. The increase in the prevalence of adrenal incidentalomas has paralleled the increase in diagnostic imaging done for evaluation of other abdominal pathologies. However, most of these adrenal incidentalomas are benign non-hyperfunctioning adenomas. When an adrenal incidentaloma is discovered, the simultaneous presence of hypokalemia, metabolic alkalosis, mild hypernatremia, and mild to severe drug-resistant hypertension may alert a clinician to underlying primary hyperaldosteronism. We present a case of adrenal incidentaloma noted in a patient with end-stage renal disease on hemodialysis which presented a diagnostic challenge due to the correction of metabolic parameters with hemodialysis. The patient was found to have an aldosterone-producing adenoma based on an elevated aldosterone-to-renin ratio and was started on a mineralocorticoid antagonist. Cureus 2020-08-07 /pmc/articles/PMC7478770/ /pubmed/32923203 http://dx.doi.org/10.7759/cureus.9599 Text en Copyright © 2020, Chand et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Chand, Raj Tandukar, Srijan Asmil, Sadiyah Chico, Michelle Primary Hyperaldosteronism in End-Stage Renal Disease: Diagnostic Challenges and Treatment Considerations |
title | Primary Hyperaldosteronism in End-Stage Renal Disease: Diagnostic Challenges and Treatment Considerations |
title_full | Primary Hyperaldosteronism in End-Stage Renal Disease: Diagnostic Challenges and Treatment Considerations |
title_fullStr | Primary Hyperaldosteronism in End-Stage Renal Disease: Diagnostic Challenges and Treatment Considerations |
title_full_unstemmed | Primary Hyperaldosteronism in End-Stage Renal Disease: Diagnostic Challenges and Treatment Considerations |
title_short | Primary Hyperaldosteronism in End-Stage Renal Disease: Diagnostic Challenges and Treatment Considerations |
title_sort | primary hyperaldosteronism in end-stage renal disease: diagnostic challenges and treatment considerations |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478770/ https://www.ncbi.nlm.nih.gov/pubmed/32923203 http://dx.doi.org/10.7759/cureus.9599 |
work_keys_str_mv | AT chandraj primaryhyperaldosteronisminendstagerenaldiseasediagnosticchallengesandtreatmentconsiderations AT tandukarsrijan primaryhyperaldosteronisminendstagerenaldiseasediagnosticchallengesandtreatmentconsiderations AT asmilsadiyah primaryhyperaldosteronisminendstagerenaldiseasediagnosticchallengesandtreatmentconsiderations AT chicomichelle primaryhyperaldosteronisminendstagerenaldiseasediagnosticchallengesandtreatmentconsiderations |